Answers are grounded in this paper and cite their sources.
Anticancer evaluation of 1,3-thiazolodin-4-one analogues reduces breast cancer markers, indicating potential as multi-target agents.
Breast cancer remains a leading cause of mortality in women, underscoring the need for multitarget therapeutic agents.
No takes yet. Share an insight, caveat, or question.
El-Zend et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: